Eli Lilly & Co. (LLY)

113.83
NYSE : Health Technology
Prev Close 112.20
Day Low/High 111.67 / 114.30
52 Wk Low/High 73.69 / 116.61
Avg Volume 4.12M
Exchange NYSE
Shares Outstanding 1.06B
Market Cap 118.86B
EPS -0.20
P/E Ratio 238.72
Div & Yield 2.25 (1.97%)

Latest News

Eli Lilly's Conservative Pricing Offers Protection From Political Pressure

Eli Lilly's Conservative Pricing Offers Protection From Political Pressure

Eli Lilly's self-policing on drug pricing protects it from the most prominent political pushbacks.

Eli Lilly's Elanco Offload Offers Acquisition Flexibility

Eli Lilly's Elanco Offload Offers Acquisition Flexibility

Eli Lilly's confirmation of acquisition action could make pharmaceuticals an attractive investment space.

Wall Street Continues to See Opportunity in Eli Lilly

Wall Street Continues to See Opportunity in Eli Lilly

LLY's stock slide after earnings might present a buying opportunity.

2 Groups to Watch as the Midterm Election Unfolds: Cannabis and Drug Stocks

2 Groups to Watch as the Midterm Election Unfolds: Cannabis and Drug Stocks

A bunch of pot stocks are in play on Tuesday -- for a reason.

Eli Lilly Offers Healthy Outlook to Kick Off November

Eli Lilly Offers Healthy Outlook to Kick Off November

The giant drugmaker raised its profit guidance for all of 2018 after its third-quarter results beat expectations.

Eli Lilly Could Hit New Highs, but Market Weakness Could Mute Gains

Eli Lilly Could Hit New Highs, but Market Weakness Could Mute Gains

It shouldn't hurt that the drugmaker beat third-quarter estimates and raised its profit guidance for all of 2018.

Jim Cramer: Keep an Eye on the Insiders Who Are Buying

Jim Cramer: Keep an Eye on the Insiders Who Are Buying

Insiders buy for only one reason -- to make money.

Jim Cramer: Even Safe-Haven Big-Cap Drug Stocks Are Now Broken

Jim Cramer: Even Safe-Haven Big-Cap Drug Stocks Are Now Broken

Once the safest stocks in the book, the big-cap drug companies are now toxic.

Eli Lilly Is Just Taking a Normal Pause

Eli Lilly Is Just Taking a Normal Pause

LLY has made a good run this year and now looks like it will correct a bit.

Jim Cramer: Avoid the Naked CEOs When the Tide Goes Out

Jim Cramer: Avoid the Naked CEOs When the Tide Goes Out

There is clear divergence between the best and the worst performers in each sector this earnings season.

Ford May Look Like a Value but It's Currently Dead Money

Ford May Look Like a Value but It's Currently Dead Money

There are concerns that interest rates may start to impact new car sales.

Constellation Brands Is a Bright Star on a Down Day

Constellation Brands Is a Bright Star on a Down Day

With STZ's earnings beat and the potential of the CGC investment, investors are willing to pay a premium.

Major Shifts in Investment Themes, Higher Interest Rates Shake up the Market

Major Shifts in Investment Themes, Higher Interest Rates Shake up the Market

This is a market driven by macro matters and is not as favorable to stock pickers right now.

Intel Regains Its Leadership Position in the Semiconductor Sector

Intel Regains Its Leadership Position in the Semiconductor Sector

The stock still needs to do more work to be convincing.

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Straying from these names could land you in quicksand as the 4th quarter begins.

Alphabet Before Congress, Fed Decision Make for an Interesting Day

Alphabet Before Congress, Fed Decision Make for an Interesting Day

Traders are likely remembering what Facebook stock did when Mark Zuckerberg testified before Congress.

A Brief Bird's Eye View of Fresh IPO Elanco Animal Health

A Brief Bird's Eye View of Fresh IPO Elanco Animal Health

The limited technical data for the recent Eli Lilly spinoff indicate buyers came in early and appear to be holding.

Eli Lilly Breaks Out of a Large Consolidation Pattern, Further Gains Ahead

Eli Lilly Breaks Out of a Large Consolidation Pattern, Further Gains Ahead

The weekly breakout is pretty impressive on the charts, so let's take a look.

Jim Cramer: 4 Pet-Related Stocks That Are Top Dog

Jim Cramer: 4 Pet-Related Stocks That Are Top Dog

The humanization of pets theme is driving outstanding earnings and share price growth for these 4 names.

Jim Cramer: How to Pick Stocks When the Market Is Flying Blind

Jim Cramer: How to Pick Stocks When the Market Is Flying Blind

This market clearly has no clue what to buy, with strong GDP growth but challenging trade dynamics and the Facebook and Twitter bombs last week.

The Race to Cure Alzheimer's is On: These Are the Forerunners

The Race to Cure Alzheimer's is On: These Are the Forerunners

Top pharmaceutical companies are paving the way to a cure for Alzheimer's, a degenerative disease that is affecting millions around the world.

Jim Cramer: We've Got an Extremist Market

Jim Cramer: We've Got an Extremist Market

Don't buy up when there's nothing but rampant pin action.

3 Ways to Play Facebook Ahead of Wednesday's Earnings

3 Ways to Play Facebook Ahead of Wednesday's Earnings

Here are some options strategies for this FANG name into tomorrow's report.

Eli Lilly Downgraded to Hold at DZ Bank

Latest Reasons to Avoid Alzheimer's Plays

Latest Reasons to Avoid Alzheimer's Plays

Eli Lilly, AstraZeneca and vTv Therapeutics show why it's best to stay away from biotech's black hole.

Jim Cramer: Many Reasons Why a Stock Market You Think Should Go Down, Doesn't

Jim Cramer: Many Reasons Why a Stock Market You Think Should Go Down, Doesn't

You should be thinking positively these days if your stock has had a run or even if it hasn't as a preponderance of good things is liable to happen.